Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Member Alert: IACP Submits FDA Comments on 503A and B 1.20.14
Share |

 


Member Alert

Monday, January 20, 2014


IACP Issues Comments on FDA's Draft Guidance: Implementation of 503A & 503B


Your Academy is the first pharmacy association to submit comments to the FDA on its Draft Guidance regarding the implementation of Section 503A and 503B of the Federal Food, Drug and Cosmetic Act.

IACP is ensuring that the voice of our pharmacy compounding members is heard! We urge our members to use our language or positions in submitting your own comments to the FDA, which are due, February 4, 2014.

IACP Comments to FDA for your Review

Please click here to view IACP's Comments on FDA's Draft Guidance on the Implementation of Section 503A.
Please click here to view IACP's Comments on FDA's Draft Guidance on the Implementation of Section 503B.
Please click here for IACP's Comparison Chart of 503A and 503B - The Drug Quality and Security Act of 2013.

IACP is Making Sure the FDA Plays by the Rules Congress Established

Today, IACP also is sending a letter to FDA Commissioner Margaret A. Hamburg, MD, expressing our specific concerns regarding what we believe is the premature nature of FDA's communication to stakeholders and State Boards, promoting conducting business with only 503B registered facilities.

"IACP continues to support increased communications between the States and FDA. However, we have strong reservations with FDA sending a letter to State stakeholders encouraging conducting business only with facilities registered as outsourcing facilities when FDA has not yet finalized guidance, restrictions, and quality standards for these 503B outsourcing facilities."

Click here to read today's letter to FDA Commissioner Hamburg.

What to Do Should you Receive Media Calls

If you receive calls from the media, IACP encourages you to direct these press inquiries directly to your Academy's PR Firm, David Ball, Ball Consulting Group This media assistance is part of your benefits as an IACP member.

David Ball, Ball Consulting Group, LLC
Office: 617-243-9950
Mobile: 617-548-7809
david@ballcg.com
www.ballcg.com

The International Academy of Compounding Pharmacists (IACP) is an association representing more than 3,600 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding.  Compounding pharmacists work directly with prescribers including physicians, nurse practitioners and veterinarians to create customized medication solutions for patients and animals whose healthcare needs cannot be met by manufactured medications. Visit www.iacprx.org to learn more.

Please email iacpinfo@iacprx.org with questions regarding this IACP Member Alert.

 

Stay connected to IACP by joining our online communities!

 

4638 Riverstone Blvd., Missouri City, TX 77459
iacpinfo@iacprx.org | Phone: 281-933-8400 | Toll-Free Referral Line: 800-927-4227
Click here to unsubscribe.
© 2014 International Academy of Compounding Pharmacists. All Rights Reserved.

 

 

 

 

Association Management Software Powered by YourMembership.com®  ::  Legal